Welcome to our dedicated page for Bausch + Lomb Corporation SEC filings (Ticker: BLCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning Bausch + Lomb’s disclosures often means sorting through pages of ophthalmic product data, FDA commentary and intangible-asset valuations. If you’re trying to discover how a new contact-lens material shapes margins or when a recall dents revenue, the details sit deep inside the 10-K and rolling 8-K updates. That complexity fuels searches like “Where can I find Bausch + Lomb’s quarterly earnings reports?� and “What do Bausch + Lomb executives disclose in Form 4?�. Stock Titan’s AI reads every footnote and delivers Bausch + Lomb SEC filings explained simply.
Our platform streams each filing the moment it hits EDGAR�10-Q, 10-K, 8-K, Section 16, S-1 and more—and converts them into plain-language insights. Want the highlights from a “Bausch + Lomb quarterly earnings report 10-Q filing�? We tag segment revenue and inventory shifts instantly. Need “Bausch + Lomb insider trading Form 4 transactions� or real-time alerts for “Bausch + Lomb executive stock transactions Form 4�? They arrive with context. Even dense proxies become digestible: “Bausch + Lomb proxy statement executive compensation� is broken into clear pay tables by our AI.
- AI-powered summaries translate complex notes into plain language
- AGÕæÈ˹ٷ½-time alerts for every Form 4 and 8-K
- Comprehensive access to all Bausch + Lomb filings
Here, “understanding Bausch + Lomb SEC documents with AI� is routine. Jump to “Bausch + Lomb 8-K material events explained,� review a “Bausch + Lomb annual report 10-K simplified� snapshot, or export numbers for your “Bausch + Lomb earnings report filing analysis.� Investors track product-line growth, surgeons follow new device approvals, and analysts watch “Bausch + Lomb Form 4 insider transactions real-time� for sentiment shifts—all without decoding legal jargon.
EVP of R&D and CMO Yehia Hashad filed a Form 4 for Bausch + Lomb (BLCO). On 07/25/2025 he disposed of 2,841 common shares at an accounting price of $14.32 under transaction code F, indicating shares were withheld solely to cover payroll-tax obligations triggered by the vesting of restricted share units. The disposition was not an open-market sale and does not change the executive’s economic exposure. After the withholding, Hashad directly owns 116,739 BLCO shares. No derivative securities were reported. The filing signals continued sizable insider ownership and appears routine rather than indicative of a change in insider sentiment.